Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist: South San Francisco, California Friday, February 21, 2 ...
Both live webcasts can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website at www.tectonictx.com. Once these conferences have concluded, a replay of the ...
A live and archived webcast will be accessible on Skye’s website.
Chimeric antigen receptor T-cell therapy has been really instrumental in how we treat patients with myeloma. It has really changed the face of how we treat this disease, so since 2021, we've had two ...
Septerna stood out from the crowd of biotech IPOs last year due to the lack of clinical data to hand. Now, the data are ...
Trial decision follows unanticipated events of elevated unconjugated bilirubin levels Company advancing multiple next-generation PTH1R agonists with distinct and unrelated chemical structures relative ...
6d
TipRanks on MSNNxera Pharma Reports Strong Revenue Growth in 2024Sosei Group Corporation ( ($SOLTF) ) has released its Q4 earnings. Here is a breakdown of the information Sosei Group Corporation presented to its ...
Researchers have discovered a new mechanism that is used by a male sex hormone essential for muscle and bone function. The ...
Researchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.
Researchers at Leipzig University’s Faculty of Medicine and Shandong University in China have discovered a new mechanism that ...
Basic science researchers at the Johns Hopkins University School of Medicine are advancing heart health research by finding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results